FDA Drug Application (201921) for LANSOPRAZOLE by NATCO PHARMA LTD

Back to FDA Applications sponsored by NATCO PHARMA LTD

Application Number201921
Product Number001
FormCAPSULE, DELAYED REL PELLETS;ORAL
Dosage15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLANSOPRAZOLE
Active IngredientLANSOPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient LANSOPRAZOLE9


Back to FDA Applications sponsored by NATCO PHARMA LTD